These results are in line with those previously seen by Troib et al. [21], which showed reduced protein expression, suggesting that a decrease in the action of GH, mediated through the JAK2/STAT5 pathway in the bone during CKD, in turn, leads to a decreased local Igf1 level. The gene discussed is JAK2; the disease is chronic kidney disease.